Detalhe da pesquisa
1.
Viruses traverse the human proteome through peptide interfaces that can be biomimetically leveraged for drug discovery.
Proc Natl Acad Sci U S A
; 121(5): e2308776121, 2024 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38252831
2.
Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy.
J Infect Dis
; 2024 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38626170
3.
Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.
Gut
; 73(4): 659-667, 2024 Mar 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37879886
4.
Helicases DDX5 and DDX17 promote heterogeneity in HBV transcription termination in infected human hepatocytes.
J Hepatol
; 2024 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38782119
5.
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics.
J Hepatol
; 2023 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36931396
6.
Profile of patients with a positive HCV viral load in a large French psychiatric hospital (2019-2021): A case-control study.
J Viral Hepat
; 30(10): 830-833, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37485610
7.
Improved hepatitis delta virus genome characterization by single molecule full-length genome sequencing combined with VIRiONT pipeline.
J Med Virol
; 95(3): e28634, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36879535
8.
Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension.
J Hepatol
; 77(6): 1525-1531, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35973578
9.
Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis.
J Hepatol
; 76(2): 464-469, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34699951
10.
Factors associated with the emergence of integrase resistance mutations in patients failing dual or triple integrase inhibitor-based regimens in a French national survey.
J Antimicrob Chemother
; 76(9): 2400-2406, 2021 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34100068
11.
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta.
J Hepatol
; 73(5): 1046-1062, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32634548
12.
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
J Hepatol
; 70(4): 615-625, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30529504
13.
Chronic Genotype 3 Hepatitis E in Pregnant Woman Receiving Infliximab and Azathioprine.
Emerg Infect Dis
; 24(5): 941-943, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29664396
14.
Very late relapse of hepatitis C virus infection immediately after liver transplant.
Am J Transplant
; 18(10): 2587-2590, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29878644
15.
Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic Cells.
Antimicrob Agents Chemother
; 62(4)2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29439958
16.
Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples.
J Med Virol
; 89(11): 1912-1919, 2017 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28590068
17.
Preliminary Evidence for Hepatitis Delta Virus Exposure in Patients Who Are Apparently Not Infected With Hepatitis B Virus.
Hepatology
; 73(2): 861-864, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32628280
18.
Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C.
Liver Int
; 37(8): 1122-1127, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28423231
19.
Hepatitis A outbreak in HIV-infected MSM and in PrEP-using MSM despite a high level of immunity, Lyon, France, January to June 2017.
Euro Surveill
; 22(48)2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-29208161
20.
Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity.
J Hepatol
; 65(3): 499-508, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27174035